IASLC CT Screening Symposium

CT Screening Symposium
Overview

The CT Screening Symposium is a 1-day, immersive, in-person event being featured at WCLC 2022 focused on lung cancer screening technologies and best practices. Using a mix of live educational presentations and real-time expert discussions, as well as interactive live Q&A opportunities, the Symposium will address topics relevant to an international audience. Faculty will provide anecdotal experience and review current data to highlight successes and address barriers to implementation of more uniform and effective lung cancer screening around the world.

Date
Aug 05, 2022 -
Aug 05, 2022
Location

Vienna, Austria

  1. Explore differences in implementation models including financial and policy implications
  2. Enhance understanding of standardized reporting of LDCT including reader education and incorporation of computer-assisted technologies
  3. Discuss the role of advanced technology and biomarkers to predict lung cancer risk and inform management decisions
  4. Understand the opportunities to leverage incidental lung nodule programs to advance the early detection of lung cancer

Learning Objectives: Explore differences in implementation models including financial, resource, political, and policy implications. 

Presentation  Start Time 
Chairs Welcome 9:00  
Session 1 Welcome 9:10 
Key Decision-Making factors in lung screening implementation  9:15 
LungPlan (Financial modeling to secure resources for lung screening and nodule management program)  9:25 
Lung Atlas - geospatial tool to direct health resources and planning  9:35 
Optimal Smoking cessation strategy  9:45 
Panel Discussion + Q&A from audience  9:55 
Conclusion  10:20 

 

Learning Objectives: Enhance understanding of standardized reporting of screening LDCT, including reader education, quality assurance, and incorporation of computer-assisted technologies

Presentation  Start Time
Session 2 Welcome 10:40 
Training, Assessment, and Standardized CAD-based Reporting - The British Columba Lung Screening Program  10:45 
IASLC education resource initiative  10:55 
Quality assurance of radiology reporting: PERFECTS 11:05 
CAD/AI in screening interpretation: from detection through management  11:15 
Panel Discussion + Q&A from audience  11:25 
Conclusion  11:50 

 

Learning Objectives: Discuss the role of advanced technologies and biomarkers to predict lung cancer risk and inform management decisions

Presentation Start Time
Welcome + Q&A from Morning Session  12:55 
Assessing lung cancer risk from a single chest CT 13:10 
Personalized risk assessment using blood and imaging biomarkers 13:20 
Deep learning approach to optimize the lung cancer screening interval 13:30 
Future directions using AI technologies for early lung cancer detection 13:40
Panel Discussion + Q&A from audience  13:50
Conclusion  14:15 

 

Learning Objectives: Understand the opportunities of leveraging lung nodule programs to advance early detection of lung cancer 

Presentation  Start Time
Session 4 Welcome 14:30 
Mass Screening using AI and liquid biopsy in China  14:35
Incidental lung nodules - an opportunity to advance early lung cancer detection 14:45
Benchmarks for diagnostic workup of early lung cancer 14:55
Additional Findings in lung cancer screening  15:05
Panel Discussion + Q&A from audience 

15:15 

Workshop summary/conclusion  15:40

 

  1. Explore differences in implementation models including financial and policy implications
  2. Enhance understanding of standardized reporting of LDCT including reader education and incorporation of computer-assisted technologies
  3. Discuss the role of advanced technology and biomarkers to predict lung cancer risk and inform management decisions
  4. Understand the opportunities to leverage incidental lung nodule programs to advance the early detection of lung cancer

Learning Objectives: Explore differences in implementation models including financial, resource, political, and policy implications. 

Presentation  Start Time 
Chairs Welcome 9:00  
Session 1 Welcome 9:10 
Key Decision-Making factors in lung screening implementation  9:15 
LungPlan (Financial modeling to secure resources for lung screening and nodule management program)  9:25 
Lung Atlas - geospatial tool to direct health resources and planning  9:35 
Optimal Smoking cessation strategy  9:45 
Panel Discussion + Q&A from audience  9:55 
Conclusion  10:20 

 

Learning Objectives: Enhance understanding of standardized reporting of screening LDCT, including reader education, quality assurance, and incorporation of computer-assisted technologies

Presentation  Start Time
Session 2 Welcome 10:40 
Training, Assessment, and Standardized CAD-based Reporting - The British Columba Lung Screening Program  10:45 
IASLC education resource initiative  10:55 
Quality assurance of radiology reporting: PERFECTS 11:05 
CAD/AI in screening interpretation: from detection through management  11:15 
Panel Discussion + Q&A from audience  11:25 
Conclusion  11:50 

 

Learning Objectives: Discuss the role of advanced technologies and biomarkers to predict lung cancer risk and inform management decisions

Presentation Start Time
Welcome + Q&A from Morning Session  12:55 
Assessing lung cancer risk from a single chest CT 13:10 
Personalized risk assessment using blood and imaging biomarkers 13:20 
Deep learning approach to optimize the lung cancer screening interval 13:30 
Future directions using AI technologies for early lung cancer detection 13:40
Panel Discussion + Q&A from audience  13:50
Conclusion  14:15 

 

Learning Objectives: Understand the opportunities of leveraging lung nodule programs to advance early detection of lung cancer 

Presentation  Start Time
Session 4 Welcome 14:30 
Mass Screening using AI and liquid biopsy in China  14:35
Incidental lung nodules - an opportunity to advance early lung cancer detection 14:45
Benchmarks for diagnostic workup of early lung cancer 14:55
Additional Findings in lung cancer screening  15:05
Panel Discussion + Q&A from audience 

15:15 

Workshop summary/conclusion  15:40

 

Share

Dr. Bai
Chunxue Bai

MD, PhD

Professor
Zhongshan Hospital, Fudan University
David R. Baldwin
David Baldwin

MD, FRCP

Honorary Professor in the School of Medicine
University of Nottingham
Dr. Kazerooni
Ella A. Kazerooni

MD, MS

Professor of Radiology and Internal Medicine
University of Michigan Medical School
Image of Dr. Lam
Stephen Lam

MD

Professor of Medicine
University of British Columbia
McWilliams_Annette
Annette McWilliams

MBBS, FRACP, MD, FRCPSC

Respiratory Physician
Fiona Stanley Hospital

Interested in advertising and exhibit opportunities?